Hear from experts as they discuss timely clinical topics as well as relevant and actionable strategies for practice improvement. This podcast is available for CME credit.
…
continue reading
1
IgA Nephropathy: Current Treatment Landscape, Disease Burden, and 2-Year PROTECT Trial Data Supporting Sparsentan as an Emerging Treatment Option
Travere Therapeutics
Listeners can expect to learn about: • The disease burden and underlying pathophysiology of IgA nephropathy, including the role of endothelin and angiotensin in disease progression • The current IgAN treatment landscape • The response to sparsentan, a dual endothelin angiotensin receptor antagonist, in patients with IgA nephropathy in the phase 3 PROTECT trial
…
continue reading
Welcome to CEConversations, a clinical podcast presented by Creative Educational Concepts designed to improve clinician performance and optimize patient outcomes.
…
continue reading
Kidney360 is ASN's first open access, online only, general kidney journal that includes content from all disciplines of kidney science. Published content includes both clinical and basic science papers. Kidney360 promises to bring you the same high-quality peer-review you've come to expect from ASN's publications.
…
continue reading
Wouldn't it be nice if someone reviewed all the latest internal medicine literature and distilled it into a brief podcast you could listen to on your way to work? Get updates from the New England Journal of Medicine, JAMA Network, Annals of Internal Medicine, Journal of Hospital Medicine, Journal of General Internal Medicine, Lancet and more.
…
continue reading
Weekly updates on new data, current advances, and best practices in patient care for a variety of medical specialties including NASH, diabetes, muscular dystrophy, and more from Clinical Care Options. Gain practical strategies and earn CME/CE credit for selected episodes.
…
continue reading
A bite-size podcast brought to you by the International Society of Glomerular Disease. Nephrologists and glomerular disease experts Dr. Kenar Jhaveri (Northwell Health/Hofstra University) and Dr. Koyal Jain (UNC Chapel Hill) take a lighthearted look at the latest research, discuss clinical practice, and interview leaders in glomerular medicine — all in a short enough time to listen on your coffee break.
…
continue reading
1
All Hands on Deck in Cervical Cancer Care: Screening, Treatment, and Equity Strategies to Improve Patient Lives
1:00:36
1:00:36
Play later
Play later
Lists
Like
Liked
1:00:36
The reduced incidence of cervical cancer over the past few decades was primarily due to robust screening guidelines and vaccinations. However, despite the proliferation of screening programs, the diagnosis of cervical cancer is associated with inefficiencies and inconsistencies and has not decreased cervical cancer incidence further over the past d…
…
continue reading
1
All Hands on Deck – Utilizing JAK Inhibitors in Myelofibrosis Care: Evidence, Timing, and Strategic Approaches
46:40
46:40
Play later
Play later
Lists
Like
Liked
46:40
Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway inhibition is the standard of care for patients with symptomatic myelofibrosis (MF); however, a significant number of hematologists/oncologists lack knowledge, competence, and confidence about JAK inhibitors (JAKis) in MF. These clinicians and their interdisciplinary c…
…
continue reading
1
Updates on Renal Denervation From the 2024 European Society of Cardiology Guidelines on Hypertension
24:36
24:36
Play later
Play later
Lists
Like
Liked
24:36
What’s changed in how we should manage resistant hypertension? Credit available for this activity expires: 9/30/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001663?ecd=bdc_podcast_libsyn_mscpedu
…
continue reading
1
Hidden Unmet Needs in Schizophrenia: What Every Healthcare Professional Needs to Know
18:59
18:59
Play later
Play later
Lists
Like
Liked
18:59
Lively Quickfire session on helping patients with cognitive and negative symptoms. Credit available for this activity expires: 9/30/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001571?ecd=bdc_podcast_libsyn_mscpedu
…
continue reading
1
Spotlight on Liver MRI: Diagnosing and Managing Hepatocellular Carcinoma
33:45
33:45
Play later
Play later
Lists
Like
Liked
33:45
In the face of the rising incidence of liver disease, how is your multidisciplinary team using imaging for surveillance and management of patients with hepatocellular carcinoma (HCC)? Credit available for this activity expires: 9/26/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001653?ecd=bdc_podcast_libs…
…
continue reading
1
A Prospective Study of Depression and Quality of Life After Kidney Transplantation
3:46
3:46
Play later
Play later
Lists
Like
Liked
3:46
In an analysis of patients undergoing kidney transplantation, depression and health related quality of life were measured at 3-months and 1-year post-transplantation. Depression and HRQOL improve with KT.By American Society of Nephrology
…
continue reading
1
Modeling Guideline-Concordant Therapy Selection in the Adjuvant Setting for Endometrial Cancer
28:24
28:24
Play later
Play later
Lists
Like
Liked
28:24
Do you know the best approaches to managing patients with endometrial cancer in the adjuvant setting? Credit available for this activity expires: 9/24/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001649?ecd=bdc_podcast_libsyn_mscpedu
…
continue reading
1
Anticoagulation in AF with Cirrhosis, Trends in Anticoagulation for Acute PE, Beta Blockers for Acute MI with Normal EF, Finerenone for HFpEF, Continuous vs Intermittent Infusion for Antibiotics, Cefepime ...
1:05:23
1:05:23
Play later
Play later
Lists
Like
Liked
1:05:23
It's been a long time, but we are back! Apologies on the audio quality from Dr. Jenkins. Apparently he was recording from inside a cardboard box. Today we talk about important, practice changing studies in internal medicine from the last several months. What's the best anticoagulant in patients with cirrhosis and atrial fibrillation? Why do doctors…
…
continue reading
1
Evolution of HER2-Targeted Therapy in Biliary Tract Cancer
24:04
24:04
Play later
Play later
Lists
Like
Liked
24:04
Do you know which type of biliary tract cancer (BTC) has the highest rate of HER2 aberrations? Credit available for this activity expires: 9/20/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001632?ecd=bdc_podcast_libsyn_mscpedu
…
continue reading
1
Spotlight on Liver MRI: Fatty Liver Disease
26:08
26:08
Play later
Play later
Lists
Like
Liked
26:08
How does magnetic resonance imaging (MRI) play a role in identifying biomarkers for patients with steatotic liver disease? Credit available for this activity expires: 9/13/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001595?ecd=bdc_podcast_libsyn_mscpedu…
…
continue reading
1
Board Review Bonus #2: Minimal Change Disease
24:56
24:56
Play later
Play later
Lists
Like
Liked
24:56
In this special bonus episode of the podcast, Koyal and Kenar provide a maximally useful review of minimal change disease, from diagnosis (including secondary causes to screen for) to treatment options, including how to decide which patients may do better with which therapies. Can’t get enough minimal change? Check out Episode 6 (with Astrid Weins)…
…
continue reading
1
Tailoring Patient Care Using Novel Agents in Metastatic Urothelial Carcinoma: Strategies for the Interprofessional Team
1:18:51
1:18:51
Play later
Play later
Lists
Like
Liked
1:18:51
The treatment paradigm in bladder cancer has fundamentally changed over the past decade, and the evolving, dense clinical trial landscape has given rise to barriers to optimizing patient care. This webcast will focus on emerging trial data for antibody-drug conjugates (ADCs); sequence optimization, combinatorial therapy utilization, and identificat…
…
continue reading
1
Paradigm Shifting Updates in IgAN: Expert Faculty Discussions of Recent Breakthroughs
18:20
18:20
Play later
Play later
Lists
Like
Liked
18:20
In this CCO Nephrology podcast episode, hear from nephrologists Pietro Canetta, MD, MS, and Andy Bomback, MD, PhD, experts in clinical management and research on glomerular diseases as they discuss key updates in managing IgAN. Faculty highlight the importance of a comprehensive supportive care regimen to protect patients’ kidneys and prevent progr…
…
continue reading
1
Cognition in Psychiatry and Schizophrenia: All You Need to Know in 15 Minutes
19:39
19:39
Play later
Play later
Lists
Like
Liked
19:39
What is processing speed? Does it matter? Learn why it absolutely does for your patients. Credit available for this activity expires: 8/3/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001439?ecd=bdc_podcast_libsyn_mscpedu
…
continue reading
1
Data Highlights in Alzheimer's Disease From the 2024 AAIC Annual Meeting
28:48
28:48
Play later
Play later
Lists
Like
Liked
28:48
What's ready for prime time and what's in the pipeline in Alzheimer’s disease (AD) diagnosis and care? View conference highlights to find out. Credit available for this activity expires: 8/29/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001535?ecd=bdc_podcast_libsyn_mscpedu…
…
continue reading
1
Mastering Multiplex Testing for Diagnosing Pneumonia: From Interpretation to Application
31:49
31:49
Play later
Play later
Lists
Like
Liked
31:49
Delve into the impact of revolutionary multiplex testing for diagnosing pneumonia. Credit available for this activity expires: 8/29/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001528?ecd=bdc_podcast_libsyn_mscpedu
…
continue reading
1
Expert Perspectives on the Future of IgA Nephropathy Treatment
30:26
30:26
Play later
Play later
Lists
Like
Liked
30:26
Recent advances in our understanding of immunoglobulin A (IgA) nephropathy (IgAN) have led to an abundance of research into new therapies; our experts will guide you through it all. Credit available for this activity expires: 8/29/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001534?ecd=bdc_podcast_libsyn…
…
continue reading
1
Breaking Down the Burden of IgA Nephropathy With Clinician and Patient Perspectives
18:01
18:01
Play later
Play later
Lists
Like
Liked
18:01
Are your patients' kidneys fighting a silent battle? Our experts give insight on earlier detection of IgAN and react to a real patient's experience. Credit available for this activity expires: 8/23/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001513?ecd=bdc_podcast_libsyn_mscpedu…
…
continue reading
1
Expert Discussions: Novel Agents Targeting Residual Inflammatory Risk in ASCVD and CKD
15:28
15:28
Play later
Play later
Lists
Like
Liked
15:28
In this CCO Nephrology podcast episode, hear from cardiologist Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC, and nephrologist Mark J. Sarnak, MD, MS, as they discuss new and emerging therapies designed to target residual inflammatory risk associated with ASCVD and CKD. Episode outline: Colchicine: inhibition of NLRP3 inflammasome assembly/…
…
continue reading
1
Expert Discussions on Residual Systemic Inflammation in ASCVD and CKD
14:32
14:32
Play later
Play later
Lists
Like
Liked
14:32
In this CCO Nephrology podcast episode, hear from cardiologist Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC, and nephrologist Mark J. Sarnak, MD, MS, as they explore new and emerging strategies to target residual risk associated with systemic inflammation in patients with ASCVD and CKD. Episode outline: The relationship among systemic infl…
…
continue reading
1
Expert Discussions: Moving Beyond Lipid Lowering to Lower Risk in ASCVD and CKD
14:32
14:32
Play later
Play later
Lists
Like
Liked
14:32
In this CCO Nephrology podcast episode, hear from cardiologist Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC, and nephrologist Mark J. Sarnak, MD, MS, as they explore the pathophysiology and novel therapeutic strategies to target residual inflammatory risk associated with ASCVD and CKD. Episode outline: Moving beyond lipid lowering to addre…
…
continue reading
1
Putting Data Into Context for Congenital Adrenal Hyperplasia Treatment Advances
26:39
26:39
Play later
Play later
Lists
Like
Liked
26:39
Do you have the latest data on novel therapies for congenital adrenal hyperplasia (CAH)? An expert panel discusses. Credit available for this activity expires: 8/23/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001510?ecd=bdc_podcast_libsyn_mscpedu
…
continue reading
1
Don't Go With Your Gut: Optimizing GI Infection Management With Rapid Diagnostic Panels
32:03
32:03
Play later
Play later
Lists
Like
Liked
32:03
How much do you know about rapid molecular diagnostics for gastrointestinal (GI) infections? Credit available for this activity expires: 08/13/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001464?ecd=bdc_podcast_libsyn_mscpedu
…
continue reading
1
Advancements and Applications of Antibody Drug Conjugates in HER2-Negative Breast Cancer
50:54
50:54
Play later
Play later
Lists
Like
Liked
50:54
Patients with triple-negative and HR-positive/HER2-negative breast cancer have limited treatment options after the development of endocrine resistance. This dearth of options is particularly acute for Black women and other marginalized patients and results in treatment disparities. Antibody-drug conjugates (ADCs) are novel agents which may improve …
…
continue reading
1
Transforming Metastatic Breast Cancer Management: Harnessing the Power of Antibody-Drug Conjugate Therapies
1:33:21
1:33:21
Play later
Play later
Lists
Like
Liked
1:33:21
Patients with triple-negative breast cancer (TNBC), and those with HR-positive/HER2-negative breast cancer after the development of endocrine resistance, have limited treatment options. Black women are diagnosed more often with TNBC and feel the lack of treatment options more acutely, leading to greater outcomes disparities. Antibody-drug conjugate…
…
continue reading
1
The Multiple Layers of Major Depressive Disorder Management: Unravelling the Who, When, and How for Antidepressant Modification
48:51
48:51
Play later
Play later
Lists
Like
Liked
48:51
What do you do when your patients are unravelling due to their antidepressant? Credit available for this activity expires: 7/26/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001393?ecd=bdc_podcast_libsyn_mscpedu
…
continue reading
1
Navigating New Waters for Advanced or Recurrent Endometrial Cancer
1:06:48
1:06:48
Play later
Play later
Lists
Like
Liked
1:06:48
Patient prognosis for endometrial cancer (EC) is highly benefited by molecular profiling, and national and international guidelines robustly recommend its integration into practice. Characterization of DNA mismatch repair (MMR) status identifies clinically significant molecular subtypes. This information assists clinicians in creating treatment pla…
…
continue reading
1
Exploring Innovations in Lung Cancer Care: Updates From Chicago
35:05
35:05
Play later
Play later
Lists
Like
Liked
35:05
Get the latest information on new lung cancer data from Chicago. Credit available for this activity expires: 7/22/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001363?ecd=bdc_podcast_libsyn_mscpedu
…
continue reading
1
Key Clinical Characteristics of IgA Nephropathy to Apply in Practice
33:44
33:44
Play later
Play later
Lists
Like
Liked
33:44
Dive into the fascinating world of immunoglobulin A nephropathy (IgAN), the most common form of primary glomerulonephritis worldwide. Credit available for this activity expires: 7/16/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001351?ecd=bdc_podcast_libsyn_mscpedu…
…
continue reading
SHOW NOTES In this episode, Koyal and Kenar recap everything you need to know about IgAN for the board exam (or just to refresh yourself on the current state of knowledge) — from pathophysiology to treatment decisions. They also discover that nobody is really sure how to pronounce Peyer’s patches (hey, don’t blame us, they’re all the way over in th…
…
continue reading
1
Building Confidence in Care: Strategies to Address Vaccine Hesitancy in Hispanic Communities
24:17
24:17
Play later
Play later
Lists
Like
Liked
24:17
Are you providing culturally competent care for your Hispanic patients? Credit available for this activity expires: 7/12/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001327?ecd=bdc_podcast_libsyn_mscpedu
…
continue reading
1
Navigating IgA Nephropathy: Insights From a Patient With Lived Experience
21:53
21:53
Play later
Play later
Lists
Like
Liked
21:53
In this CCO Nephrology podcast episode, hear from Kelly Chen, a nephrology nurse practitioner and patient living with IgA nephropathy, as she discusses her experiences with Dr Pietro Canetta, Associate Professor of Medicine at Columbia University and expert in glomerular diseases. Episode outline: Seeking and obtaining an IgAN diagnosis Patient sel…
…
continue reading
1
Navigating Relapsed/Refractory CLL/SLL Together: Where Disease-, Treatment-, and Patient-Centered Care Unite
1:14:02
1:14:02
Play later
Play later
Lists
Like
Liked
1:14:02
Did you know 59% of patients value doctors asking about their information needs and desired level of care involvement? Join us to explore these and other insights in relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL). Credit available for this activity expires: 7/5/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.o…
…
continue reading
1
Navigating Patient-Centered Care of CLL and MCL: Empowering Collaboration and Communication
52:08
52:08
Play later
Play later
Lists
Like
Liked
52:08
Are you aware of the DREAM protocol that can facilitate a 2-way exchange between patients and clinicians? Credit available for this activity expires: 6/28/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001200?ecd=bdc_podcast_libsyn_mscpedu
…
continue reading
1
Unmasking Cognitive Impairment and Negative Symptoms in Schizophrenia
38:18
38:18
Play later
Play later
Lists
Like
Liked
38:18
Short on time? You can still screen for these function-limiting symptoms. Credit available for this activity expires: 6/26/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001208?ecd=bdc_podcast_libsyn_mscpedu
…
continue reading
1
What's on the Horizon in Atopic Dermatitis? A Focus on OX40-OX40 Ligand-Targeted Therapies
29:15
29:15
Play later
Play later
Lists
Like
Liked
29:15
Did you know that targeting the OX40-OX40 ligand (OX40-OX40L) pathway may lead to long-term remission in atopic dermatitis (AD)? Credit available for this activity expires: 6/26/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001214?ecd=bdc_podcast_libsyn_mscpedu…
…
continue reading
1
Expert Opinions on Treating Metabolic Dysfunction-Associated Steatohepatitis
17:29
17:29
Play later
Play later
Lists
Like
Liked
17:29
How would you manage a patient with metabolic syndrome and metabolic dysfunction-associated steatohepatitis? Credit available for this activity expires: 6/26/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001260?ecd=bdc_podcast_libsyn_mscpedu
…
continue reading
1
Connecting With the Experts at ASCO 2024: Clinical Pearls and Data Insights About Anti-HER2 Therapies in Biliary Tract Cancer
24:15
24:15
Play later
Play later
Lists
Like
Liked
24:15
Get the latest data from ASCO 2024 about anti-HER2 therapies in biliary tract cancer. Credit available for this activity expires: 6/25/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001250?ecd=bdc_podcast_libsyn_mscpedu
…
continue reading
Are you aware of patients’ perceptions and wishes about diagnosis and management of transthyretin amyloid cardiomyopathy (ATTR-CM)? Credit available for this activity expires: 6/18/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001176?ecd=bdc_podcast_libsyn_mscpedu…
…
continue reading
1
Quiz Time! Test Your Knowledge on Treatments for Gastroesophageal Reflux Disease
1:12:31
1:12:31
Play later
Play later
Lists
Like
Liked
1:12:31
How much do you know about new acid suppressive treatments for gastroesophageal reflux disease (GERD)? Credit available for this activity expires: 6/12/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001195?ecd=bdc_podcast_libsyn_mscpedu
…
continue reading
1
What's New in the Treatment of Gastroesophageal Reflux Disease and Erosive Esophagitis: Spring Meeting Updates
1:12:31
1:12:31
Play later
Play later
Lists
Like
Liked
1:12:31
Hear from 3 experts as they discuss the latest clinical knowledge on the management of gastroesophageal reflux disease (GERD) and erosive esophagitis. Credit available for this activity expires: 6/11/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001184?ecd=bdc_podcast_libsyn_mscpedu…
…
continue reading
1
EHA2024 Chronic Lymphocytic Leukemia Preview: The Road Ahead With Targeted Therapies
33:47
33:47
Play later
Play later
Lists
Like
Liked
33:47
Join the experts for an in-depth discussion on the latest developments in targeted therapies for relapsed/refractory chronic lymphocytic leukemia (R/R CLL), and a look ahead to the upcoming EHA2024 conference. Credit available for this activity expires: 6/6/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1…
…
continue reading
1
There Are Multiple Ways to Treat R/R CLL or R/R MCL: What Would the Experts Do?
59:02
59:02
Play later
Play later
Lists
Like
Liked
59:02
Listen to the experts discuss treatment options for relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL) and R/R mantle cell lymphoma (MCL) in 4 unique patient cases. Credit available for this activity expires: 06/07/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000852?ecd=bdc_podcast_libsyn_mscpe…
…
continue reading
1
Multiple Sclerosis Biosimilars in the United States: How to Communicate With Your Patient for Successful Implementation
19:25
19:25
Play later
Play later
Lists
Like
Liked
19:25
Do you know how to have a heads-up conversation about biosimilars? Credit available for this activity expires: 6/6/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001162?ecd=bdc_podcast_libsyn_mscpedu
…
continue reading
1
Episode 7: Felicitas Hengel and Nicola Tomas on a New Chapter in Anti-Nephrin Autoantibodies
16:15
16:15
Play later
Play later
Lists
Like
Liked
16:15
In this episode, we talk with Dr. Felicitas Hengel, MD and Dr. Nicola Tomas, MD (both at the University Medical Center Hamburg-Eppendorf) about their groundbreaking anti-nephrin autoantibody research that was just presented at the 2024 ERA Congress and published in the New England Journal of Medicine. Is this a game-changer for minimal change? How …
…
continue reading
1
To Switch or Not to Switch: Patient Case Discussions on Integrating Biosimilars in Multiple Sclerosis Care
29:22
29:22
Play later
Play later
Lists
Like
Liked
29:22
What are the main indicators that a patient with multiple sclerosis (MS) can be switched to a biosimilar? Credit available for this activity expires: 5/31/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000864?ecd=bdc_podcast_libsyn_mscpedu
…
continue reading
1
Enhancing Equitable HIV Care With Long-Acting Injectable Antiretrovirals: Why It Matters
20:03
20:03
Play later
Play later
Lists
Like
Liked
20:03
Are you doing all you can to provide equitable care to persons with HIV or those at risk for HIV infection? Credit available for this activity expires: 5/31/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001139?ecd=bdc_podcast_libsyn_mscpedu
…
continue reading
1
International Expert Recommendations for Timely and Accurate Diagnosis of Alzheimer's Disease in Primary Care
41:25
41:25
Play later
Play later
Lists
Like
Liked
41:25
What is the primary care clinician's role in diagnosing early stages of Alzheimer's disease, and what kinds of assessments can they use? Credit available for this activity expires: 5/31/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000858?ecd=bdc_podcast_libsyn_mscpedu…
…
continue reading
How would you manage this patient? Credit available for this activity expires: 5/31/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001135?ecd=bdc_podcast_libsyn_mscpedu
…
continue reading
1
Episode 6: Astrid Weins on Anti-Nephrin Antibodies and Nephropathology
17:23
17:23
Play later
Play later
Lists
Like
Liked
17:23
In this episode, Kenar and Koyal interview Dr. Astrid Weins, MD, PhD, about nephropathology, new approaches to solving the mysteries of nephrotic syndrome, and her research on anti-nephrin antibodies in minimal change disease. Dr. Weins is Chief of Integrated Renal Pathology at Mass General/Brigham and an Assistant Professor of Pathology at Harvard…
…
continue reading